A stepwise progression in the treatment of cardiogenic shock.

[1]  C. Toma,et al.  Extracorporeal membrane oxygenation for advanced refractory shock in acute and chronic cardiomyopathy. , 2011, The Annals of thoracic surgery.

[2]  P. Loyalka,et al.  The percutaneous ventricular assist device in severe refractory cardiogenic shock. , 2011, Journal of the American College of Cardiology.

[3]  Eun-Seok Jeon,et al.  Extracorporeal cardiopulmonary resuscitation in patients with inhospital cardiac arrest: A comparison with conventional cardiopulmonary resuscitation* , 2011, Critical care medicine.

[4]  G. Richardt,et al.  Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. , 2010, The American journal of cardiology.

[5]  Adnan Kastrati,et al.  A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. , 2008, Journal of the American College of Cardiology.

[6]  Judith S. Hochman,et al.  Cardiogenic Shock: Current Concepts and Improving Outcomes , 2008, Circulation.

[7]  D. Burkhoff,et al.  A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. , 2006, American heart journal.

[8]  C. Hoermann,et al.  Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. , 2006, The Annals of thoracic surgery.

[9]  J. Tijssen,et al.  Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. , 2006, The American journal of cardiology.

[10]  N. Chi,et al.  Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue* , 2006, Critical care medicine.

[11]  Roland Hetzer,et al.  Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. , 2004, The Annals of thoracic surgery.

[12]  M. Olschewski,et al.  The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. , 2004, The Journal of thoracic and cardiovascular surgery.

[13]  J. Hochman,et al.  Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. , 2003, Circulation.

[14]  M. Prins,et al.  An association between atherosclerosis and venous thrombosis. , 2003, The New England journal of medicine.

[15]  G. Schuler,et al.  Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. , 2003, European heart journal.

[16]  J. Heit.  Venous Thromboembolism Epidemiology: Implications for Prevention and Management , 2002, Seminars in thrombosis and hemostasis.

[17]  R. Bartlett,et al.  The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. , 2001, The Annals of thoracic surgery.

[18]  N. Smedira,et al.  Postcardiotomy mechanical support: risk factors and outcomes. , 2001, The Annals of thoracic surgery.

[19]  A. Jaffer,et al.  Demystifying two common genetic predispositions to venous thrombosis. , 2000, Cleveland Clinic journal of medicine.

[20]  R. Califf,et al.  Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. , 1999, Circulation.

[21]  S. Chillcott,et al.  Long-term survival with use of percutaneous extracorporeal life support in patients presenting with acute myocardial infarction and cardiovascular collapse. , 1999, ASAIO journal.

[22]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[23]  J. Gurwitz,et al.  Temporal trends in cardiogenic shock complicating acute myocardial infarction. , 1999, The New England journal of medicine.

[24]  E R Bates,et al.  Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.

[25]  K. Okamoto,et al.  Emergency and long‐term extracorporeal life support following acute myocardial infarction: Rescue from severe cardiogenic shock related to stunned myocardium , 1994, Clinical cardiology.

[26]  O. Hess,et al.  Preservation of myocardial function by mechanical circulatory support during prolonged ischaemia. , 1992, European heart journal.

[27]  P. Loyalka,et al.  Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.